ICON Net Income 2010-2024 | ICLR

ICON annual/quarterly net income history and growth rate from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • ICON net income for the quarter ending September 30, 2024 was $0.197B, a 20.45% increase year-over-year.
  • ICON net income for the twelve months ending September 30, 2024 was $0.748B, a 45.69% increase year-over-year.
  • ICON annual net income for 2023 was $0.612B, a 21.18% increase from 2022.
  • ICON annual net income for 2022 was $0.505B, a 229.87% increase from 2021.
  • ICON annual net income for 2021 was $0.153B, a 53.91% decline from 2020.
ICON Annual Net Income
(Millions of US $)
2023 $612
2022 $505
2021 $153
2020 $332
2019 $374
2018 $323
2017 $281
2016 $262
2015 $240
2014 $172
2013 $103
2012 $55
2011 $23
2010 $87
2009 $94
ICON Quarterly Net Income
(Millions of US $)
2024-09-30 $197
2024-06-30 $147
2024-03-31 $187
2023-12-31 $216
2023-09-30 $164
2023-06-30 $116
2023-03-31 $117
2022-12-31 $117
2022-09-30 $160
2022-06-30 $116
2022-03-31 $112
2021-12-31 $76
2021-09-30 $-94
2021-06-30 $74
2021-03-31 $97
2020-12-31 $101
2020-09-30 $92
2020-06-30 $48
2020-03-31 $92
2019-12-31 $99
2019-09-30 $95
2019-06-30 $92
2019-03-31 $88
2018-12-31 $88
2018-09-30 $85
2018-06-30 $72
2018-03-31 $78
2017-12-31 $71
2017-09-30 $74
2017-06-30 $65
2017-03-31 $71
2016-12-31 $74
2016-09-30 $64
2016-06-30 $61
2016-03-31 $63
2015-12-31 $64
2015-09-30 $62
2015-06-30 $59
2015-03-31 $56
2014-12-31 $54
2014-09-30 $50
2014-06-30 $41
2014-03-31 $36
2013-12-31 $33
2013-09-30 $28
2013-06-30 $22
2013-03-31 $19
2012-12-31 $21
2012-09-30 $18
2012-06-30 $13
2012-03-31 $9
2011-12-31 $4
2011-09-30 $-3
2011-06-30 $13
2011-03-31 $8
2010-12-31 $22
2010-09-30 $20
2010-06-30 $23
2010-03-31 $22
2009-12-31 $31
2009-09-30 $24
2009-06-30 $19
2009-03-31 $21
Sector Industry Market Cap Revenue
Medical Medical Services $18.679B $8.120B
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
Revvity (RVTY) United States $15.535B 26.63
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Charles River Laboratories (CRL) United States $9.742B 18.41
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00